Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Ariad Pharmaceuticals hired Paris Panayiotopoulos as chief executive officer and president. Currently, he is president of EMD Serono and previously worked at Eli Lilly.

Merus hired Hui Liu as chief business officer;


eFFECTOR Therapeutics hired Alana McNulty as chief financial officer;

Barclays hired Christine Poon as a senior advisor in its healthcare banking group;


Dicerna Pharmaceuticals named John “Jack” Green as interim chief financial officer;

Vanda Pharmaceuticals named Gian Piero Reverberi as senior VP, acting chief commercial officer;

Medigene named Dolores Schendel as chief executive officer;

Medigene named Dave Lemus as chief operating officer;

Immunocore hired James Sandy as chief development officer;

Immunocore hired Julian Hirst as director of corporate finance;

Evofem hired Sandra Matsumoto as vice president of global regulatory affairs;

BIND Therapeutics hired Jonathan Yingling as chief scientific officer;

Aimmune Therapeutics hired Jeffrey Knapp as chief operating officer;

Aclaris Therapeutics hired Brett Fair as senior vice president of commercial operations;

HUYA Bioscience International hired Scott Garrett as vice president, commercial planning;

BioDelivery Sciences International promoted Niraj Vasisht to senior VP and chief technology officer;

BioDelivery Sciences International promoted Albert Medwar to senior VP, corporate business development;

BioDelivery Sciences International named Dr. Sarah DeRossett as VP, clinical research & medical affairs;

US Pharmacopeial Convention hired Dr. Salah Kivlighn as senior VP, strategic marketing and program operations.